Climate change,urbanisation,changes habitats, trade & travel mosquitoes, especially Aedes, adapting to new environment & thriving. Also ticks.This has & increasingly spread disease new regions. Dengue biggest concern but so to Zika, JE, CEE & WN & others https://t.co/sUxIhQ1LVj
The GLP-1 drugs are the most important drug class breakthrough in medical history. We're still learning how they have such broad impact, especially about their anti-inflammatory effects, systemically and in the brain
https://t.co/jZ49W1QItw
A new feature @Nature, by @marilenharo
Noteworthy progress in cancer treatment.
Not long ago, KRAS, one of the most important driver mutations, was considered undruggable (i.e. no Rx).
Now there are 2 drugs approved and this discovery of a single molecule that inactivates 13 of 17 of KRAS's most common mutations @ScienceMagazine
https://t.co/8pG4yhLjIP
@alessiociulli@UoDCeTPD
📌Our #PATRICIA trial shows that a new chemotherapy-free combination reduces the risk of progression by 48% and improves tolerability in a molecularly selected group of patients with advanced breast cancer
👩⚕️These results have just been presented by our Vice President, Dr. @evaciruelos at #ASCO24 👇
👀🔗 https://t.co/vIEwXUhlOp
@prat_aleix @ASCO #beSOLTI
Santiago Ramón will present at @ForoTransfiere the 13th European Meeting on Science, Technology, and Innovation on 22 March at 11.15am on:
“Transforming Drug Development using advanced pharmacological technologies: the hollow fiber system at the University of Zaragoza”
Our approach to women at risk of—and who live with—cancer needs to change. 2.3 million women die prematurely from cancer each year. Why? Because “patriarchy dominates cancer care, research, and policy making.” Power is life.
🎉Celebrating 20 years
EDCTP was established on this date 20 years ago.
We invited representatives of our member countries, current and former members of our advisory bodies, and other partners to share their views on the EDCTP programme⤵️
https://t.co/bbwu33JWJZ
The measure of your intelligence is not your ability to acquire knowledge but how you handle uncertainty and navigate through it and behave when you don't know what to do.
Are you an African researcher? We seek your experience, perception, and opinion on the research environment and practice. Take the African Research Culture Survey in
English, French or Portuguese. @KEMRI_Wellcome@ScienceForumSA@wellcometrust @MlwTrust
https://t.co/CDhslVkhKP
Join us for this special event: learning from 12 years #OneHealth research and operation in #Africa by a cohort of 72 fellows under the DELTAS Africa initiative supported through @SciforAfrica@wellcometrust
News reporters talk about “the migrants” as if they are some kind of alien species. Those risking their lives to come to the UK are people—men, women, and children. Please stop using this othering word and refer to them as they are—our fellow human beings.
Major investment in science infrastructure, human resource training and education will enable Africa to lead from the front in ensuring more Africans lead productive and healthier lives. And together we can!
Mark your calendars! On 17 October, the Tenth #EDCTPForum will kick off with this year’s theme “Equity in research for health”. The Forum will be hosted virtually, with some live sessions from Maputo, Mozambique. View the programme & register: https://t.co/T0vRKiniJE
Join the 10th EDCTP Forum "Equity in research for health"
⭐️When: 17-21 October 2021
⭐️Hybrid
⭐️Registration: free
⭐️More info: https://t.co/WgqlaV0uif
@WHOAFRO@AfricaCDC@dsw_intl@EMA_News@eu
Those of us who were born in Tanzania are so very proud of the Nobel Prize for Literature awarded to fellow Tanzania-born Abdulrazak Gurnah. I have read all his books and I recommend them to you!
⁉️What is the accountability of 💉 Boards of Directors for 🌍 vaccine inequity & its ☠️ consequences? What is the responsibility of 💲institutional investors?
Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor - The New York Times https://t.co/6hDk2V1Pbi